— Know what they know.
Not Investment Advice
Also trades as: TRLV (NYSE) · $vol 17M · TRUL.CN (CNQ) · $vol 3M

TCNNF OTC

Trulieve Cannabis Corp.
1W: +5.3% 1M: +23.9% 3M: +26.7% YTD: +40.8% 1Y: +37.6% 3Y: +227.5% 5Y: -55.2%
$12.25
-0.02 (-0.16%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 67 · $2.4B mcap · 168M float · 1.06% daily turnover · Short 36% of daily vol

Income Trends

Revenue
$1.2B +1.3% ▲
5Y CAGR: +18.2%
Gross Profit
$604M -15.6% ▼
5Y CAGR: +9.3%
Operating Income
$162M +65.2% ▲
5Y CAGR: -5.8%
Net Income
-$118M +23.7% ▲
EPS (Diluted)
$-0.62 +24.4% ▲
EBITDA
$334M +29.1% ▲
5Y CAGR: +10.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$938M$1.2B$1.1B$1.2B$1.2B
YoY Growth+79.9%+32.1%-8.9%+5.1%+1.3%
Cost of Revenue$372M$558M$541M$471M$598M
Gross Profit$566M$682M$589M$716M$604M
Gross Margin60.3%55.0%52.1%60.3%50.2%
R&D Expenses$0$0$0$0$0
SG&A Expenses$316M$455M$386M$510M$442M
Operating Expenses$364M$574M$810M$618M$442M
Operating Income$197M$109M-$222M$98M$162M
Operating Margin21.0%8.8%-19.6%8.2%13.4%
Interest Expense$29M$73M$82M$62M$65M
Income Before Tax$164M-$43M-$285M$43M$93M
Tax Expense$146M$162M$151M$198M$212M
Net Income$18M-$205M-$527M-$155M-$118M
Net Margin1.9%-16.5%-46.7%-13.1%-9.9%
EPS (Diluted)$0.12$-1.09$-2.84$-0.82$-0.62
EBITDA$284M$240M-$33M$259M$334M
Shares Outstanding147M188M189M190M191M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms